日韩精品久久一区二区三区_亚洲色图p_亚洲综合在线最大成人_国产中出在线观看_日韩免费_亚洲综合在线一区

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

CIIE helps Bristol Myers Squibb expand China footprint

By Cao Chen in Shanghai | chinadaily.com.cn | Updated: 2021-06-29 16:33
Share
Share - WeChat
Visitors make inquiries at the stand of Bristol-Myers Squibb during the second China International Import Expo in Shanghai on Nov 9, 2019. [Photo by Lyu Liang/For China Daily]

The China International Import Expo has been a major platform for US biopharmaceutical enterprise Bristol-Myers Squibb to bring its experience in immuno-oncology treatment to the Chinese market and showcase its scientific and innovative achievements, said Chen Siyuan, general manager of Bristol-Myers Squibb China and Hong Kong.

At the third expo held in Shanghai last year, the company unveiled its five-year strategy tailored to the domestic market. The strategy involves accelerating the introduction of nearly 30 innovative drugs to the market, increasing the number of employees in its R&D and commercial teams, growing its investment in China and introducing the latest product lines to China to benefit more patients.

The company also reached a series of agreements with local partners in China at the third CIIE, including a contract with domestic health platform JD Health to establish an online liver disease innovation platform that would improve accessibility of the drug Baraclude, which is used to treat hepatitis B infection of the liver.

Data shows the platform helped raise online sales of the drug, which accounted for 12.5 percent of the company's sales in the first quarter.

A strategic relationship also was established between the company and Hainan Boao Lecheng International Medical Tourism Pilot Zone in South China's Hainan province. According to this partnership, the company's latest products will be first made available in the zone.

The company attended the expo for the first time in 2019 and displayed an immunotherapy drug, Opdivo. According to the company, a Nobel Prize laureate contributed to the development of this drug.

Opdivo has since been approved for use in the treatment of lung cancer, head and neck cancer, and gastric cancer in China.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 在线免费观看h片 | 一区二区三区国产免费 | av激情在线 | 欧洲成人全免费视频网站 | 国产成人高清 | 精品毛片| 久热综合| 深夜做爰性大片中文 | 国产精品成人免费视频不卡 | 日韩欧美一区二区三区免费观看 | 欧美系列第一页 | 国产精品视频观看 | 国内精品一区二区在线观看 | 久久精品一区二区 | 欧美 亚洲 一区 | 一区二区三区日韩在线观看 | 日韩在线欧美 | 日本黄色免费片 | 中国人xxxxx18 | 我想看免费毛片 | 亚洲 欧美 日韩 在线 香蕉 | 亚洲综合久久久久久中文字幕 | 亚洲欧美影视 | 国产欧美精品一区二区三区 | 国产精品毛片久久久久久 | 波多野结衣中文在线播放 | 精品久久久久久久人人人人传媒 | 九九精品视频一区在线 | 欧美美女动态图 | 青草香蕉精品视频在线观看 | 韩国三级中文字幕hd久久精品 | 国产aaa毛片| 五月亚洲综合 | 亚洲一区无码中文字幕 | 午夜影院观看 | 秋霞影院精品久久久久 | 搜一级毛片| 黄色毛片视频 | 99久久久国产精品 | 国产福利免费在线观看 | 无码乱人伦一区二区亚洲 |